Screener
Ultragenyx Pharmaceutical RARE PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's PP&E (net)?
- Ultragenyx Pharmaceutical (RARE) reported PP&E (net) of $235M in Q2 2026.
- How has Ultragenyx Pharmaceutical's PP&E (net) changed year-over-year?
- Ultragenyx Pharmaceutical's PP&E (net) decreased by 8.1% year-over-year, from $255.76M to $235M.
- What is the long-term trend for Ultragenyx Pharmaceutical's PP&E (net)?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's PP&E (net) has grown at a 27.1% compound annual growth rate (CAGR), from $73.52M to $244M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Ultragenyx Pharmaceutical's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude